Cardiometabolic Effects of Denosumab in Premenopausal Women with Breast Cancer Receiving Estradiol Suppression: RCT.

Sabashini K RamchandRudolf HoermannShane WhiteBelinda YeoPrudence A FrancisCecilia L H XuJeffrey D ZajacEgo SeemanMathis Grossmann

Published in: The Journal of clinical endocrinology and metabolism (2024)

In premenopausal women receiving estradiol suppression, denosumab decreases some measures of fat mass with no detectable effects on other measures of body composition or metabolic parameters.

Keyphrases

bone mineral density
body composition
postmenopausal women
breast cancer risk
resistance training
estrogen receptor
polycystic ovary syndrome
adipose tissue
giant cell
early breast cancer
pregnancy outcomes
fatty acid
metabolic syndrome
cervical cancer screening
skeletal muscle
pregnant women